RNS Number : 1329I
13 November 2008
13 November, 2008
Publication of Prospectus
The following Supplementary Prospectus has been approved by the UK Listing Authority and is available for viewing:
1st Supplementary Prospectus dated November 13, 2008 relating to a U.S.$18,000,000,000 Euro Medium Term Note Programme of Québec.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus dated June 18, 2008 as amended by a Supplementary Prospectus dated November 13, 2008 (together, the 'Prospectus') may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the 'Securities Act') and are subject to US tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered in the United States or to or for the account of US persons (as defined in Regulation S under the Securities Act).
Your right to access this service is conditional upon complying with the above requirement.
To view the full document, please paste the following URLs into the address bar of your browser.
Supplementary Prospectus dated November 13, 2008
Exhibit 99.8 of the Amendment dated November 13 2008 to the Issuer's Annual Report (on Form 18-K/A) for the fiscal year ended 31 March 2008 (containing the Consolidated Financial Statements - Volume 1 of the Public Accounts 2007-2008) incorporated by reference in the Supplementary Prospectus
For further information, please contact:
Financing of Public Organizations and Financial Documentation
Telephone Number: 1-418-643-8141
Fax Number: 1-418-643-4700
This information is provided by RNS
The company news service from the London Stock Exchange